FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2147119208> ?p ?o ?g. }

• W2147119208 endingPage "155" @default.
• W2147119208 startingPage "148" @default.
• W2147119208 abstract "To determine the efficacy of small doses of radiation in patients with recurrent or refractory low-grade lymphoma masses. Patients with refractory or relapsing low-grade lymphoma masses. The two largest diameters of the tumor mass were measured, whenever possible, before and after treatment. A dose of 4 Gy of radiotherapy was delivered to tumor sites in 2 fractions. Patients were evaluated for response 1–4 months later and at regular follow-up visits. Forty-eight patients with low-grade lymphomas according to the working formulation received low-dose radiotherapy between March 1987 and November 1998. Most patients had advanced disease at the time of radiation treatment, and 80% had received at least two chemotherapy regimens before treatment. The median interval between the initial diagnosis and radiotherapy was 2.7 years (range 0–22 years). Low-dose radiation was delivered to 135 tumor sites. Nodal and extranodal tumor sites represented 80% and 20% of masses, respectively. An objective response was obtained in 81% of the sites, with 57% attaining a complete remission. The 2-year actuarial freedom from local progression (FFLP) rate was 56% (95% CI, 46–66%). Tumor masses ≤5 cm in diameter had a significantly higher 2-year FFLP rate than larger masses (51% vs. 27%). It is noteworthy that the 2-year FFLP rate for patients treated with less than 2 chemotherapy regimens before radiotherapy was significantly higher than the 2-year FFLP rate for more heavily treated patients (96% vs. 48%). The 2-year FFLP rates for extranodal tumor sites and nodal sites were not significantly different. The tumor size (≤5 cm vs. >5 cm), the number of chemotherapy regimens (0–1 vs. more), and age at time of radiation treatment (≤65 years or > 65 years) were significant predictive parameters of response to treatment. In this retrospective study, low-dose radiation proved efficient, with long-lasting effects in the majority of patients with recurrent or refractory low-grade lymphomas. This simple and nontoxic treatment should be investigated prospectively in patients with advanced disease and a low tumor burden not immediately warranting chemotherapy." @default.
• W2147119208 created "2016-06-24" @default.
• W2147119208 creator A5018336376 @default.
• W2147119208 creator A5026485141 @default.
• W2147119208 creator A5029716239 @default.
• W2147119208 creator A5030811791 @default.
• W2147119208 creator A5032462496 @default.
• W2147119208 creator A5033561428 @default.
• W2147119208 creator A5063423094 @default.
• W2147119208 creator A5070508738 @default.
• W2147119208 creator A5073216761 @default.
• W2147119208 creator A5074635776 @default.
• W2147119208 creator A5083080728 @default.
• W2147119208 creator A5083914679 @default.
• W2147119208 date "2001-09-01" @default.
• W2147119208 modified "2023-10-06" @default.
• W2147119208 title "A high and sustained response rate in refractory or relapsing low-grade lymphoma masses after low-dose radiation: analysis of predictive parameters of response to treatment" @default.
• W2147119208 cites W1550247880 @default.
• W2147119208 cites W1819590342 @default.
• W2147119208 cites W1874821077 @default.
• W2147119208 cites W1967858500 @default.
• W2147119208 cites W1969751970 @default.
• W2147119208 cites W1979574823 @default.
• W2147119208 cites W1981852548 @default.
• W2147119208 cites W2018685233 @default.
• W2147119208 cites W2040699587 @default.
• W2147119208 cites W2059682256 @default.
• W2147119208 cites W2079742386 @default.
• W2147119208 cites W2084194788 @default.
• W2147119208 cites W2088514036 @default.
• W2147119208 cites W2162976098 @default.
• W2147119208 cites W2169950926 @default.
• W2147119208 cites W2203017689 @default.
• W2147119208 cites W2324989751 @default.
• W2147119208 cites W4230324843 @default.
• W2147119208 doi "https://doi.org/10.1016/s0360-3016(01)01626-1" @default.
• W2147119208 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11516864" @default.
• W2147119208 hasPublicationYear "2001" @default.
• W2147119208 type Work @default.
• W2147119208 sameAs 2147119208 @default.
• W2147119208 citedByCount "62" @default.
• W2147119208 countsByYear W21471192082012 @default.
• W2147119208 countsByYear W21471192082013 @default.
• W2147119208 countsByYear W21471192082014 @default.
• W2147119208 countsByYear W21471192082016 @default.
• W2147119208 countsByYear W21471192082017 @default.
• W2147119208 countsByYear W21471192082018 @default.
• W2147119208 countsByYear W21471192082019 @default.
• W2147119208 countsByYear W21471192082020 @default.
• W2147119208 countsByYear W21471192082021 @default.
• W2147119208 countsByYear W21471192082023 @default.
• W2147119208 crossrefType "journal-article" @default.
• W2147119208 hasAuthorship W2147119208A5018336376 @default.
• W2147119208 hasAuthorship W2147119208A5026485141 @default.
• W2147119208 hasAuthorship W2147119208A5029716239 @default.
• W2147119208 hasAuthorship W2147119208A5030811791 @default.
• W2147119208 hasAuthorship W2147119208A5032462496 @default.
• W2147119208 hasAuthorship W2147119208A5033561428 @default.
• W2147119208 hasAuthorship W2147119208A5063423094 @default.
• W2147119208 hasAuthorship W2147119208A5070508738 @default.
• W2147119208 hasAuthorship W2147119208A5073216761 @default.
• W2147119208 hasAuthorship W2147119208A5074635776 @default.
• W2147119208 hasAuthorship W2147119208A5083080728 @default.
• W2147119208 hasAuthorship W2147119208A5083914679 @default.
• W2147119208 hasConcept C121332964 @default.
• W2147119208 hasConcept C126322002 @default.
• W2147119208 hasConcept C141071460 @default.
• W2147119208 hasConcept C142424586 @default.
• W2147119208 hasConcept C2776694085 @default.
• W2147119208 hasConcept C2779338263 @default.
• W2147119208 hasConcept C2989005 @default.
• W2147119208 hasConcept C509974204 @default.
• W2147119208 hasConcept C71924100 @default.
• W2147119208 hasConcept C87355193 @default.
• W2147119208 hasConceptScore W2147119208C121332964 @default.
• W2147119208 hasConceptScore W2147119208C126322002 @default.
• W2147119208 hasConceptScore W2147119208C141071460 @default.
• W2147119208 hasConceptScore W2147119208C142424586 @default.
• W2147119208 hasConceptScore W2147119208C2776694085 @default.
• W2147119208 hasConceptScore W2147119208C2779338263 @default.
• W2147119208 hasConceptScore W2147119208C2989005 @default.
• W2147119208 hasConceptScore W2147119208C509974204 @default.
• W2147119208 hasConceptScore W2147119208C71924100 @default.
• W2147119208 hasConceptScore W2147119208C87355193 @default.
• W2147119208 hasIssue "1" @default.
• W2147119208 hasLocation W21471192081 @default.
• W2147119208 hasLocation W21471192082 @default.
• W2147119208 hasOpenAccess W2147119208 @default.
• W2147119208 hasPrimaryLocation W21471192081 @default.
• W2147119208 hasRelatedWork W2003938723 @default.
• W2147119208 hasRelatedWork W2047967234 @default.
• W2147119208 hasRelatedWork W2118496982 @default.
• W2147119208 hasRelatedWork W2351796763 @default.
• W2147119208 hasRelatedWork W2364998975 @default.
• W2147119208 hasRelatedWork W2416632858 @default.
• W2147119208 hasRelatedWork W2439875401 @default.
• W2147119208 hasRelatedWork W2567738959 @default.
• W2147119208 hasRelatedWork W4238867864 @default.

• next